PTC Therapeutics | PTCT - 资产



金融业
股票价格
USD
资产
USD 3.25B
现金及等价物
USD 1.05B
销售成本
USD 39.61M
流动资产
USD 2.62B
流动负债
USD 771.07M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD 61.98M
员工
939
EPS每股收益
USD 0.92
股本和储备
USD -165.36M
销售毛利
USD 232.94M
债务利息支出
USD 3.25B
贷款资金
USD 535.52M
市值
USD 5.44B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 82.88M
PE价格收益
8.76
税前利润
USD -2.46M
销售收入
USD 361M
销售和管理费用
USD 73.89M
股票
USD 91.35M
贸易债权人
USD 40.45M
应收帐款人
USD 219.92M


资产 更改 日
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amgen USD 95.64B 3.14B 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Biogen USD 32.09B 2.6B 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Cytokinetics USD 1.92B 651.07M 2026-06
Daiichi Sankyo JPY 4.11T 109.16B 2026-06
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Gilead Sciences USD 49.36B 6.92B 2026-06
Incyte USD 7.87B 533.53M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 202.86M 7.95M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06
Xencor USD 724.96M 11.89M 2026-06